Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study

Laura M. Legue*, Felice N. van Erning, Nienke Bernards, Valery E. P. P. Lemmens, Ignace H. J. T. de Hingh, Geert-Jan Creemers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)699-705
Number of pages7
JournalTargeted Oncology
Volume14
Issue number6
Early online date17 Oct 2019
DOIs
Publication statusPublished - Dec 2019

Keywords

  • PHASE-II
  • COLORECTAL-CANCER
  • PANITUMUMAB PLUS
  • SUPPORTIVE CARE
  • OPEN-LABEL
  • FLUOROURACIL
  • OXALIPLATIN
  • LEUCOVORIN
  • IRINOTECAN
  • CAPECITABINE

Cite this